Taysha Gene Therapies Inc. (TSHA)
NASDAQ · Healthcare
Taysha Gene Therapies Inc. Cash on Hand 2022–2025
Taysha Gene Therapies Inc. annual cash on hand history from 2022 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Taysha Gene Therapies Inc. cash on hand as of December 31, 2025: 319.8M, a 129.99% increase year-over-year.
- Taysha Gene Therapies Inc. cash on hand for 2025 were 319.8M, a 129.99% increase from 2024.
- Taysha Gene Therapies Inc. cash on hand for 2024 were 139.0M, a 3.41% decrease from 2023.
- Taysha Gene Therapies Inc. cash on hand for 2023 were 143.9M, a 63.79% increase from 2022.
- Taysha Gene Therapies Inc. cash on hand for 2022 were 87.9M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Taysha Gene Therapies Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $320 |
| 2024 | $139 |
| 2023 | $144 |
| 2022 | $88 |
Taysha Gene Therapies Inc. Cash on Hand — FAQ
Taysha Gene Therapies Inc. (TSHA) cash on hand over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TSHA's cash on hand history?
The chart and table above show Taysha Gene Therapies Inc.'s cash on hand by year and by quarter, including the growth rate.